EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoretâ„¢ in Neovascular Age Related Macular Degeneration and Diabetic Macular Edema
- AMARONE (Anti-permeability Mechanism and Age-Related Ocular Neovascularization Evaluation) is first clinical trial of EyeBio’s…